Search Within

Chaitanya Bandlamudi

Formats
  1. Journal Article (46)
  2. Meeting Abstract (31)
  3. Guidelines (2)
  4. Research Letter (2)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (82)
  2. GSK Faculty (81)
  3. Human Oncology and Pathogenesis Program (77)
  4. Department of Medicine (76)
  5. Solid Tumor Oncology Division (75)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (70)

More Groups

People
  1. Michael Berger (55)
  2. David Solit (35)
  3. Zsofia Stadler (35)
  4. Diana Mandelker (34)
  5. Barry Taylor (32)
  6. Kenneth Offit (32)

More People

Years
  1. 2025 (9)
  2. 2024 (6)
  3. 2023 (15)
  4. 2022 (15)
  5. 2021 (6)
  6. 2020 (14)

More Years

Publications
  1. Journal of Clinical Oncology (18)
  2. Clinical Cancer Research (12)
  3. Cancer Research (9)
  4. Annals of Oncology (6)
  5. Nature (6)
  6. Cancer (5)

More Publications

Publishers
  1. American Association for Cancer Research (24)
  2. American Society of Clinical Oncology (21)
  3. Nature Publishing Group (14)
  4. Oxford University Press (8)
  5. Wiley Blackwell (5)
  6. Cell Press (4)

More Publishers

Results (82)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • POT1 germline pathogenic variants and evolving understanding of tumor spectrum: Evidence for lung cancer predisposition
    Meeting Abstract

    Walsh, M. F.; Mukherjee, S.; Gao, M.; Fiala, E.; Mauguen, A.; Kemel, Y.; Bandlamudi, C.; Mehine, M.; Carlo, M. I.; Murciano-Goroff, Y. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes
    Meeting Abstract

    Joseph, V.; Ravichandran, V.; Ostrovnaya, I.; Liu, Y. L.; Tkachuk, K.; Khurram, A.; Kemel, Y.; Mandelker, D.; Bandlamudi, C.; Walsh, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and molecular features of long-term response to anti-PD-(L)1 therapy in patients with advanced non-small cell lung cancer
    Meeting Abstract

    Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Luo, J.; Alessi, J. V. M.; Pecci, F.; Lamberti, G.; Hong, Lingzhi; Plodkowski, A. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pathogenic germline variants in patients with endometrial cancer across diverse ancestries
    Meeting Abstract

    Liu, Y. L.; Gordhandas, S.; Arora, K.; Maio, A.; Kemel, Y.; Sheehan, M.; Salo-Mullen, E. E.; Zhou, Q.; Iasonos, A.; Selenica, P.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Association of smoking history extracted from electronic health records (EHR) using machine-learning methods and tumor characteristics in patients with lung cancer
    Meeting Abstract

    Mukherjee, S.; Schroeder, A.; Chatterjee, S.; Cadley, J.; Falcon, C. J.; Mehine, M.; Bandlamudi, C.; Chatterjee, A.; Ladanyi, M.; Solit, D. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinicopathologic, genomic, and immunophenotypic landscape of ATM mutations in non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Elkrief, A.; Alessi, J.; Wang, X.; Li, Y.; Gupta, H.; Muldoon, D. M.; Bertram, A. A.; Pecci, F.; Lamberti, G.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations
    Guidelines

    Kuzbari, Z.; Bandlamudi, C.; Loveday, C.; Garrett, A.; Mehine, M.; George, A.; Hanson, H.; Snape, K.; Kulkarni, A.; Allen, S.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes for IDH1 mutant biliary tract cancer (BTC) treated with contemporary systemic therapy
    Meeting Abstract

    Cowzer, D.; Huq, R.; Perry, M.; Keane, F.; Park, W.; El Dika, I. H.; Khalil, D.; Shia, J.; Sigel, C. S.; Bandlamudi, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations
    Journal Article

    Mandelker, D.; Marra, A.; Mehta, N.; Selenica, P.; Yelskaya, Z.; Yang, C.; Somar, J.; Mehine, M.; Misyura, M.; Basturk, O.; more...
    npj Precision Oncology (2023)

    Fulltext@MSK | Save
  • NBN pathogenic germline variants are associated with pan-cancer susceptibility and in vitro DNA damage response defects
    Journal Article

    Belhadj, S.; Khurram, A.; Bandlamudi, C.; Palou-Márquez, G.; Ravichandran, V.; Steinsnyder, Z.; Wildman, T.; Catchings, A.; Kemel, Y.; Mukherjee, S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save